These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 12177434)

  • 1. Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.
    Nowakowski A; Wang C; Powers DB; Amersdorfer P; Smith TJ; Montgomery VA; Sheridan R; Blake R; Smith LA; Marks JD
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11346-50. PubMed ID: 12177434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
    J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
    Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations.
    Diamant E; Lachmi BE; Keren A; Barnea A; Marcus H; Cohen S; David AB; Zichel R
    PLoS One; 2014; 9(1):e87089. PubMed ID: 24475231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D.
    Garcia-Rodriguez C; Yan S; Geren IN; Knopp KA; Dong J; Sun Z; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
    Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
    Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD
    Protein Eng Des Sel; 2011 Mar; 24(3):321-31. PubMed ID: 21149386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
    Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
    J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of neutralizing mouse-human chimeric and shuffling antibodies against botulinum neurotoxin A.
    Mukamoto M; Maeda H; Kohda T; Nozaki C; Takahashi M; Kozaki S
    Microbiol Immunol; 2012 Nov; 56(11):748-55. PubMed ID: 22938032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
    Smith TJ; Lou J; Geren IN; Forsyth CM; Tsai R; Laporte SL; Tepp WH; Bradshaw M; Johnson EA; Smith LA; Marks JD
    Infect Immun; 2005 Sep; 73(9):5450-7. PubMed ID: 16113261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBC Adherence of Immune Complexes Containing Botulinum Toxin Improves Neutralization and Macrophage Uptake.
    Al-Saleem FH; Sharma R; Puligedda RD; Elias M; Kattala CD; Simon PM; Simpson LL; Dessain SK
    Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28534855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of monoclonal antibody to botulinum neurotoxin type B light chain by phage display.
    Lee MS; Lee JC; Choi CY; Chung J
    Hybridoma (Larchmt); 2008 Feb; 27(1):18-24. PubMed ID: 18294072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B.
    Yang GH; Kim KS; Kim HW; Jeong ST; Huh GH; Kim JC; Jung HH
    Toxicon; 2004 Jul; 44(1):19-25. PubMed ID: 15225558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization.
    Marks JD
    Mov Disord; 2004 Mar; 19 Suppl 8():S101-8. PubMed ID: 15027061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a neutralizing monoclonal antibody against botulinum neurotoxin serotype F, following vaccination with active toxin.
    Brown DR; Lloyd JP; Schmidt JJ
    Hybridoma; 1997 Oct; 16(5):447-56. PubMed ID: 9388028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.
    Garcia-Rodriguez C; Razai A; Geren IN; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
    Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29494481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
    MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.
    Chen C; Wang S; Wang H; Mao X; Zhang T; Ji G; Shi X; Xia T; Lu W; Zhang D; Dai J; Guo Y
    PLoS One; 2012; 7(8):e43845. PubMed ID: 22952786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.
    MAbs; ; . PubMed ID: 24492304
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.